Exposure to ALS-FTD-CSF Generates TDP-43 Aggregates in Glioblastoma Cells Through Exosomes and TNTs-like Structure
Overview
Authors
Affiliations
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) represent a continuum of devastating neurodegenerative diseases, characterized by transactive response DNA-binding protein of 43 kDa (TDP-43) aggregates accumulation throughout the nervous system. Despite rapidly emerging evidence suggesting the hypothesis of 'prion-like propagation' of TDP-43 positive inclusion in the regional spread of ALS symptoms, whether and how TDP-43 aggregates spread between cells is not clear. Herein, we established a cerebrospinal fluid (CSF)-cultured cell model to dissect mechanisms governing TDP-43 aggregates formation and propagation. Remarkably, intracellular TDP-43 mislocalization and aggregates were induced in the human glioma U251 cells following exposure to ALS-FTD-CSF but not ALS-CSF and normal control (NC) -CSF for 21 days. The exosomes derived from ALS-FTD-CSF were enriched in TDP-43 C-terminal fragments (CTFs). Incubation of ALS-FTD-CSF induced the increase of mislocated TDP-43 positive exosomes in U251 cells. We further demonstrated that exposure to ALS-FTD-CSF induced the generations of tunneling nanotubes (TNTs)-like structure and exosomes at different stages, which mediated the propagation of TDP-43 aggregates in the cultured U251 cells. Moreover, immunoblotting analyses revealed that abnormal activations of apoptosis and autophagy were induced in U251 cells, following incubation of ALS-CSF and ALS-FTD-CSF. Taken together, our data provide direct evidence that ALS-FTD-CSF has prion-like transmissible properties. TNTs-like structure and exosomes supply the routes for the transfer of TDP-43 aggregates, and selective inhibition of their over-generations may interrupt the progression of TDP-43 proteinopathy.
Picard F, Nonaka T, Belotti E, Osseni A, Errazuriz-Cerda E, Jost-Mousseau C Cell Mol Life Sci. 2025; 82(1):76.
PMID: 39948244 PMC: 11825969. DOI: 10.1007/s00018-025-05589-w.
Stavrovskaya A, Voronkov D, Pavlova A, Olshanskiy A, Belugin B, Ivanova M Acta Naturae. 2025; 16(4):73-80.
PMID: 39877010 PMC: 11771849. DOI: 10.32607/actanaturae.27499.
Kumari S, Lausted C, Scherler K, Ng A, Lu Y, Lee I Biomolecules. 2025; 14(12.
PMID: 39766306 PMC: 11674167. DOI: 10.3390/biom14121599.
Jeon S, Jeon Y, Lim J, Kim Y, Cha B, Kim W Signal Transduct Target Ther. 2025; 10(1):4.
PMID: 39757214 PMC: 11701242. DOI: 10.1038/s41392-024-02070-1.
Sulek A Postep Psychiatr Neurol. 2024; 33(3):147-162.
PMID: 39678458 PMC: 11635433. DOI: 10.5114/ppn.2024.144686.